Select Past Investments
 

BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. The company offers industry-leading medical imaging services, enterprise eClinical technologies, clinical research centers and cardiovascular safety solutions that bring quality and efficiency to every phase of clinical development. BioClinica’s experience spans three decades and includes thousands of studies in all therapeutic areas.

INVESTMENT STRATEGY

JLL in partnership with Water Street merged BioClinica and CCBR-SYNARC in 2014 to transform the company into a leading provider of specialty outsourced clinical services.​


Increasing Demand: Global pharma R&D expenditures represent $120 billion and are expected to grow by over $10 billion during the next five years. BioClinica is the industry's leading imaging platform within the technology-based outsourced clinical trial services industry. The company serves more than 400 pharmaceutical, biotechnology, and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. BioClinica is well-positioned to address this attractive market opportunity as pharmaceutical companies and CROs continue to outsource highly specialized functions to third parties.


Visit BioClinica